17th Biennial International Photodynamic Association World Congress

项目总结/摘要 国际光动力学协会（IPA）的使命是促进基础、转化和临床 光动力疗法（PDT）和光诊断（PD）的研究，涉及治疗和 使用称为光敏剂的光激活分子诊断人类疾病。IPA将举办第17届 两年一次的世界大会将在马萨诸塞州剑桥的波士顿剑桥酒店举行 2019年6月28日至7月4日。会议将由哈佛大学教授Tayyaba Hasan博士主持 他在主持和组织科学会议方面拥有丰富的经验。概要 会议计划在这里提出。该计划的重点是：1。希望会议将于 两位诺贝尔奖获得者的演讲激励了年轻的科学家。2.）的情况。PDT学校 向广大受众提供该领域的概况。3.）第三章一个临床研讨会，以突出最近的FDA和其他 在全球范围内批准相关药物和设备，并确定图像引导的前进方向 切除术和图像引导PDT。(No人类受试者）。4.）研讨会/集思广益会议， 临床医生、基础科学家、工程师、NIH人员、行业和风险投资代表， “影响路线图”，PDT和PD可能占据独特的利基。5.）帮助早期职业生涯的活动 科学家、年轻的研究人员、妇女和少数民族，这些群体传统上 在科学中代表性不足，以建立网络，以帮助维持对PDT和PD的兴趣。 与过去的会议一样，这次会议将汇集学生，博士后研究员，独立 研究人员，来自行业的代表，以及从事PDT和PD研究的临床医生， 信息，分享前沿发现和遇到的挑战，并鼓励合作， 有效地将PDT和PD技术应用于临床。为此，一些领导 该领域的研究人员承诺支持会议，并同意介绍他们的工作， 以受邀演讲的形式提供他们对该领域的看法。学生、研究人员和行业代表将 请提交口头或海报介绍的摘要，然后由 会议计划委员会。将举办一系列工作坊和讨论会， 来自基础，转化，临床和工业研究背景的与会者之间的互动。的 本申请所要求的大部分资金将用于为注册提供财政援助 以及为那些在科学领域传统上代表性不足的群体的个人提供旅行。因为这 国会将在十年内首次在美国举行，我们预计国会议员将非常兴奋。 社区，特别是为研究人员和公司设在美国，并预计400-600与会者。的 对公众健康的影响将来自光学成像应用的“影响路线图”， PDT在医学中的应用是会议精神的基础。

Project Summary / Abstract The mission of the International Photodynamic Association (IPA) is to promote basic, translational, and clinical research in photodynamic therapy (PDT) and photodiagnosis (PD), modalities which involve treatment and diagnosis of human disease using light-activated molecules called photosensitizers. The IPA is hosting the 17th Biennial World Congress to be held in handicap accessible Boston Marriot Cambridge Hotel in Cambridge, MA from June 28-July 4, 2019. The conference will be chaired by Dr. Tayyaba Hasan, Professor at Harvard Medical School, who has extensive experience chairing and organizing scientific conferences. A summary of the Conference plan is presented here. Highlights of the plan are: 1.) It is hoped that the Conference will open with lectures from 2 Nobel Laureates to inspire the young and established scientists. 2.) PDT School to provide an overview of the field to a broad audience. 3.) A clinical workshop to highlight recent FDA and other worldwide approvals regarding relevant drugs and devices, and to identify a way forward for Image Guided Resection and Image-Guided PDT. (No human subjects). 4.) A workshop/brainstorming session with clinicians, basic scientists, engineers, NIH personnel, industry and venture capital representatives to carve a “Roadmap for Impact” where PDT & PD may occupy a unique niche. 5.) Events to assist early career scientists, young investigators, women, and minorities from groups that have been traditionally underrepresented in science to network to help sustain interest in PDT & PD. As with past meetings, this conference will bring together students, postdoctoral fellows, independent researchers, representatives from industry, and clinicians practicing and researching PDT & PD to exchange information, share cutting-edge discoveries and challenges encountered, and encourage collaboration in order to effectively translate PDT & PD based technologies into the clinic. To this end, a number of leading researchers in the field have committed their support for the conference and agreed to present their work and offer their perspective on the field in the form of invited lectures. Students, researchers, and industry reps will be invited to submit abstracts for either oral or poster presentations, which will be then be selected by the conference Program Committee. A series of workshops and discussion sessions will be held to facilitate interaction among attendees from basic, translational, clinical, and industrial research backgrounds. The majority of funds requested in this application would go towards providing financial assistance for registration and travel for individuals from groups that have been traditionally underrepresented in science. As this Congress will be held in the USA for the first time in a decade, we expect significant excitement among the community, especially for researchers and companies based in the US, and anticipate 400-600 attendees. The impact on public health will be derived from the “Roadmap for Impact” for applications of Optical Imaging and PDT in medicine that underlies the ethos of the conference.